AEON Biopharma, Inc.
AEON · XNYSCIK 1837607fmd_14RAAC4Z4C4F8N29374NSDKZWQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Jun 30, 2026, 22 periods
Latest annual · FY2025
Millions- Operating income
- (13)
- Net income
- (39)
- Free cash flow
- (17)
Latest quarter · Q2 FY2026
Millions- Operating income
- (6)
- Net income
- (1)
Daily close · AEONIEX trades only
Aug 06, 2025 to Nov 11, 2026 · 250 sessions0.18 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
AEON Biopharma, Inc. (AEON) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$12.8 million | $73 million | -117.5% | 10-K 2026-03-30 · proof |
| Net income | -$39.2 million | $42 million | -193.4% | 10-K 2026-03-30 · proof |
| Cash from operating activities | -$17.3 million | -$20.3 million | 10-K 2026-03-30 · proof | |
| Free cash flow | -$17.3 million | 10-K 2026-03-30 · proof | ||
| Total assets | $5.6 million | $3.1 million | +77% | 10-K 2026-03-30 · proof |
| Total liabilities | $60.6 million | $31.7 million | +91.1% | 10-K 2026-03-30 · proof |
| Cash and cash equivalents | $3 million | $13,000 | +23,023.1% | 10-K 2026-03-30 · proof |
- What was AEON Biopharma, Inc. (AEON)'s operating income in fiscal 2025?
- AEON Biopharma, Inc. (AEON) reported operating income of -$12.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $73 million the year before (-117.5%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was AEON Biopharma, Inc. (AEON)'s net income in fiscal 2025?
- AEON Biopharma, Inc. (AEON) reported net income of -$39.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $42 million the year before (-193.4%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was AEON Biopharma, Inc. (AEON)'s cash from operating activities in fiscal 2025?
- AEON Biopharma, Inc. (AEON) reported cash from operating activities of -$17.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$20.3 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was AEON Biopharma, Inc. (AEON)'s free cash flow in fiscal 2025?
- AEON Biopharma, Inc. (AEON) reported free cash flow of -$17.3 million for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are AEON Biopharma, Inc. (AEON)'s total assets?
- As of Dec 31, 2025, AEON Biopharma, Inc. (AEON) reported total assets of $5.6 million, against $3.1 million a year earlier (+77%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are AEON Biopharma, Inc. (AEON)'s total liabilities?
- As of Dec 31, 2025, AEON Biopharma, Inc. (AEON) reported total liabilities of $60.6 million, against $31.7 million a year earlier (+91.1%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are AEON Biopharma, Inc. (AEON)'s cash and cash equivalents?
- As of Dec 31, 2025, AEON Biopharma, Inc. (AEON) reported cash and cash equivalents of $3 million, against $13,000 a year earlier (+23,023.1%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:AEON&period_type=annual&limit=5"Information only, not investment advice.